Comments on: Mitoxantrone Plus Prednisone – A Possible Fallback After Taxotere Failure http://advancedprostatecancer.net/?p=626 Sharing experiences, support and advice for men with advanced & recurrent Prostate Cancer Tue, 07 Sep 2010 11:59:15 +0000 http://wordpress.org/?v=2.9.2 hourly 1 By: Svetlana Tasker http://advancedprostatecancer.net/?p=626&cpage=1#comment-100480 Svetlana Tasker Tue, 03 Aug 2010 04:20:05 +0000 http://advancedprostatecancer.net/?p=626#comment-100480 Say, you got a nice blog article.Really looking forward to read more. Great. Say, you got a nice blog article.Really looking forward to read more. Great.

]]> By: Tom Escott http://advancedprostatecancer.net/?p=626&cpage=1#comment-61733 Tom Escott Mon, 20 Jul 2009 21:58:47 +0000 http://advancedprostatecancer.net/?p=626#comment-61733 I, too, was docetaxel-refractory with mHRPC in February 2009. I was in considerable pain from bone metastases. I was, however, fortunate to be accepted into a phase III clinical trial that included MP plus Ixabepilone, all FDA approved, but not in combination. I receive the M&I infusion every three weeks. The prednisone I take twice daily. Since March, my PSA has dropped 87%, to 8.5. I was pain-free in the first month of the trial. Scans have not revealed any new cancer progression. The side effects are tolerable and have been reduced through weight loss, better diet, and exercise. I, too, was docetaxel-refractory with mHRPC in February 2009. I was in considerable pain from bone metastases. I was, however, fortunate to be accepted into a phase III clinical trial that included MP plus Ixabepilone, all FDA approved, but not in combination. I receive the M&I infusion every three weeks. The prednisone I take twice daily.

Since March, my PSA has dropped 87%, to 8.5. I was pain-free in the first month of the trial. Scans have not revealed any new cancer progression. The side effects are tolerable and have been reduced through weight loss, better diet, and exercise.

]]>